Furthermore, we tested these compounds in chordoma cells to determine their utility for direct targeting of an essential transcription factor, explore the phenotypic and transcriptional consequences of TBXT inhibition, and identify components of the gene network regulated by TBXT that could be new entry points for therapeutic intervention. The gene discussed is TBXT; the disease is chordoma.